Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

A recent study found that the respiratory and non-respiratory symptom burden in patients with COPD is high when compared with ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

These symptoms could be early signs of COPD (Chronic Obstructive Pulmonary Disease), a progressive lung disease that is one of the leading causes of illness and death worldwide. COPD is caused by ...

Could both indoor and outdoor air pollution significantly worsen respiratory health in patients with COPD? Find out.

In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...

The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with ...

Long COVID development may be influenced by severity of the initial COVID-19 illness and preexisting respiratory conditions, including COPD and OSA.

Over the last decade, as other companies—such as AstraZeneca with IL-5 inhibitor Fasenra—struggled to advance candidates for COPD, Regeneron and Sanofi took a more “phenotype-driven approach ...

The drug was cleared for use in adults whose COPD symptoms aren’t under control and whose disease is driven by eosinophils, a type of immune cell that can contribute to inflammation. There are ...